HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Ohishi, K. Articles by Yamanouchi, K. Search for Related Content PubMed PubMed Citation Articles by Ohishi, K. Articles by Yamanouchi, K. Agricola Articles by Ohishi, K. Articles by Yamanouchi, K.

Long-term protective immunity to rinderpest in cattle following a single vaccination with a recombinant vaccinia virus expressing the virus haemagglutinin protein

Institute for Animal Health, Pirbright Laboratory, Woking, Surrey GU24 0NF, UK¹
Nippon Institute for Biological Science, 9-2221-1 Shin-machi, Ome, Tokyo 198-00024, Japan²

Author for correspondence: Thomas Barrett. Fax +44 1483 232448. e-mail tom.barrett{at}bbsrc.ac.uk

A recombinant vaccine, produced by using a highly attenuated smallpox vaccine (LC16mO) as a vector and which expresses the rinderpest virus (RPV) haemagglutinin protein, has been developed. The properties of this vaccine, including its heat stability, efficacy in short-term trials, safety and genetic stability, have been confirmed in an earlier report. In the present study, the duration of the protective immunity generated by the vaccine in cattle was examined for up to 3 years following the administration of a single vaccination dose of 10⁸ p.f.u. The vaccinated cattle were kept for 2 (group I) or 3 years (group II) and then challenged with a highly virulent strain of RPV. Four of five vaccinated cattle in group I and all six cattle in group II survived the challenge, some showing solid immunity without any clinical signs of rinderpest. Neutralizing antibodies were maintained at a significant level for up to 3 years and they increased rapidly following challenge. Lymphocyte proliferative responses to RPV were examined in group II cattle and were observed in four of the six vaccinated cattle in this group. The long-lasting protective immunity, in addition to the other properties confirmed previously, indicate the practical usefulness of this vaccine for field use.

This article has been cited by other articles:

				G. Berhe, C. Minet, C. Le Goff, T. Barrett, A. Ngangnou, C. Grillet, G. Libeau, M. Fleming, D. N. Black, and A. Diallo Development of a Dual Recombinant Vaccine To Protect Small Ruminants against Peste-des-Petits-Ruminants Virus and Capripoxvirus Infections J. Virol., December 20, 2002; 77(2): 1571 - 1577. [Abstract] [Full Text] [PDF]

				M. Yoneda, S. K. Bandyopadhyay, M. Shiotani, K. Fujita, A. Nuntaprasert, R. Miura, M. D. Baron, T. Barrett, and C. Kai Rinderpest virus H protein: role in determining host range in rabbits J. Gen. Virol., June 1, 2002; 83(6): 1457 - 1463. [Abstract] [Full Text] [PDF]

				P. H. Verardi, F. H. Aziz, S. Ahmad, L. A. Jones, B. Beyene, R. N. Ngotho, H. M. Wamwayi, M. G. Yesus, B. G. Egziabher, and T. D. Yilma Long-Term Sterilizing Immunity to Rinderpest in Cattle Vaccinated with a Recombinant Vaccinia Virus Expressing High Levels of the Fusion and Hemagglutinin Glycoproteins J. Virol., January 15, 2002; 76(2): 484 - 491. [Abstract] [Full Text] [PDF]

				E. P. Walsh, M. D. Baron, L. F. Rennie, P. Monaghan, J. Anderson, and T. Barrett Recombinant Rinderpest Vaccines Expressing Membrane-Anchored Proteins as Genetic Markers: Evidence of Exclusion of Marker Protein from the Virus Envelope J. Virol., November 1, 2000; 74(21): 10165 - 10175. [Abstract] [Full Text]